Additionally, Zhao and colleagues (115) postulated that the upregulation of vimentin mediated by TGF-β might also account for the accelerated acquisition of gefitinib resistance in NSCLC cells. The gene discussed is TGFB1; the disease is non-small cell lung carcinoma.